Analysts See $-0.51 EPS for Cara Therapeutics, Inc. (CARA); Rockshelter Capital Management Boosted Spirit Airlines (SAVE) Stake

July 12, 2018 - By Mike Johnson

Spirit Airlines, Inc. (NYSE:SAVE) Logo

Rockshelter Capital Management Llc increased Spirit Airlines Inc. (SAVE) stake by 18.12% reported in 2018Q1 SEC filing. Rockshelter Capital Management Llc acquired 54,165 shares as Spirit Airlines Inc. (SAVE)’s stock declined 5.11%. The Rockshelter Capital Management Llc holds 353,161 shares with $13.34 million value, up from 298,996 last quarter. Spirit Airlines Inc. now has $2.72B valuation. The stock increased 10.30% or $3.72 during the last trading session, reaching $39.85. About 4.25 million shares traded or 238.24% up from the average. Spirit Airlines, Inc. (NASDAQ:SAVE) has declined 29.77% since July 12, 2017 and is downtrending. It has underperformed by 42.34% the S&P500. Some Historical SAVE News: 26/04/2018 – SPIRIT AIRLINES SEES EFFECTIVE TAX RATE 24% IN 2Q, FY; 28/03/2018 – Chicago O’Hare $8.5 bln expansion plan approved by city council; 12/04/2018 – More Caribbean, More Go! Spirit Airlines Celebrates New Service to Cap-H; 10/04/2018 – SPIRIT AIRLINES INC – NOW ESTIMATES ITS 2018 FULL YEAR CASM EX-FUEL WILL BE DOWN BETWEEN 3 AND 4 PERCENT YEAR OVER YEAR; 09/03/2018 – CNBC: BREAKING: Spirit Airlines asks FAA for system-wide ground stop for all its flights due to computer issues.…; 02/04/2018 – SPIRIT AIRLINES TO BUY 14 A319-100 AIRCRAFT FOR $285M; 04/05/2018 – Wells Capital Buys New 1.3% Position in Spirit Air; 11/04/2018 – SPIRIT AIRLINES INC SAVE.N : DEUTSCHE BANK RAISES TARGET PRICE TO $60 FROM $58; 11/05/2018 – Spirit Airlines would be the first U.S. ultra-low cost carrier to offer Wi-Fi on board; 26/04/2018 – Spirit Airlines 1Q Adj EPS 44c

Analysts expect Cara Therapeutics, Inc. (NASDAQ:CARA) to report $-0.51 EPS on August, 2.They anticipate $0.22 EPS change or 75.86% from last quarter’s $-0.29 EPS. After having $-0.51 EPS previously, Cara Therapeutics, Inc.’s analysts see 0.00% EPS growth. The stock increased 1.44% or $0.31 during the last trading session, reaching $21.83. About 775,513 shares traded. Cara Therapeutics, Inc. (NASDAQ:CARA) has risen 1.86% since July 12, 2017 and is uptrending. It has underperformed by 10.71% the S&P500. Some Historical CARA News: 15/05/2018 – Nexthera Capital Buys New 1.1% Position in Cara Therapeutics; 23/05/2018 – CARA TO GET $70M INVESTMENT UP FRONT; UP TO $470M MILESTONES; 09/03/2018 – CARA OPERATIONS LTD – QTRLY EARNINGS PER SHARE FROM CONTINUING OPERATIONS ATTRIBUTABLE TO COMMON SHAREHOLDERS $0.45; 12/03/2018 – Sen. Hassan: Senator Hassan Leads Roundtable Discussion on Importance of Passing Bipartisan CARA 2.0 Act to Support Public; 30/04/2018 – CARA NAMES FRANK HENNESSEY AS CEO, AS BILL GREGSON MOVES INTO E; 23/05/2018 – CARA THERAPEUTICS INC – CARA IS ELIGIBLE TO RECEIVE TIERED ROYALTIES BASED ON NET SALES OF KORSUVA INJECTION IN LICENSED TERRITORIES; 10/05/2018 – CARA OPERATIONS LTD CARA.TO – QTRLY ADJUSTED DILUTED EPS $0.41; 12/03/2018 – Cara Therapeutics Coverage Assumed by H.C. Wainwright at Buy; 10/05/2018 – CARA OPERATIONS LTD CARA.TO – SAME RESTAURANT SALES GROWTH FOR QUARTER WAS 2.1% COMPARED TO SAME 13 WEEKS IN 2017; 23/05/2018 – CARA THERAPEUTICS INC – CARA ELIGIBLE FOR UP TO $470 MLN IN REGULATORY AND COMMERCIAL MILESTONES

Since March 15, 2018, it had 0 insider purchases, and 1 sale for $75,425 activity. $75,425 worth of Spirit Airlines, Inc. (NYSE:SAVE) was sold by Bendoraitis John A. on Thursday, March 15.

More notable recent Spirit Airlines, Inc. (NYSE:SAVE) news were published by: Seekingalpha.com which released: “Spirit Airlines: Fuel Prices Are Causing Overselling” on July 12, 2018, also Seekingalpha.com with their article: “Wolfe Research updates on Spirit Airlines” published on July 12, 2018, Bizjournals.com published: “Spirit Airline’s plan to welcome additional flights to OIA signals more on the horizon” on June 19, 2018. More interesting news about Spirit Airlines, Inc. (NYSE:SAVE) were released by: Bizjournals.com and their article: “Orlando airport kicks off flights to another Brazilian destination” published on July 11, 2018 as well as Seekingalpha.com‘s news article titled: “Airline fares drop in the US” with publication date: July 03, 2018.

Among 12 analysts covering Spirit Airlines (NASDAQ:SAVE), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Spirit Airlines had 21 analyst reports since January 16, 2018 according to SRatingsIntel. The stock of Spirit Airlines, Inc. (NYSE:SAVE) has “Buy” rating given on Friday, April 27 by Imperial Capital. The firm has “Buy” rating by Citigroup given on Tuesday, May 29. On Wednesday, February 7 the stock rating was maintained by Cowen & Co with “Hold”. Morgan Stanley maintained it with “Equal-Weight” rating and $42 target in Wednesday, February 7 report. The firm has “Hold” rating by Cowen & Co given on Wednesday, April 11. As per Wednesday, February 7, the company rating was upgraded by Macquarie Research. Buckingham Research maintained Spirit Airlines, Inc. (NYSE:SAVE) on Friday, March 2 with “Neutral” rating. Deutsche Bank maintained the stock with “Buy” rating in Wednesday, April 11 report. The firm has “Equal-Weight” rating given on Thursday, April 12 by Morgan Stanley. On Monday, April 30 the stock rating was maintained by Citigroup with “Buy”.

Investors sentiment decreased to 0.9 in Q1 2018. Its down 0.03, from 0.93 in 2017Q4. It is negative, as 23 investors sold SAVE shares while 80 reduced holdings. 38 funds opened positions while 55 raised stakes. 71.29 million shares or 3.68% less from 74.01 million shares in 2017Q4 were reported. American Int Gp Inc reported 1,429 shares. First Personal Financial reported 1,265 shares or 0.01% of all its holdings. Prelude Mngmt has invested 0% in Spirit Airlines, Inc. (NYSE:SAVE). State Street Corp owns 0% invested in Spirit Airlines, Inc. (NYSE:SAVE) for 926,024 shares. Dekabank Deutsche Girozentrale holds 0.06% or 240,700 shares. 45,900 are held by Raymond James & Assocs. Alliancebernstein Ltd Partnership accumulated 0% or 39,640 shares. 367,665 are held by New York State Common Retirement Fund. Olstein Cap Management Limited Partnership holds 1.43% of its portfolio in Spirit Airlines, Inc. (NYSE:SAVE) for 298,500 shares. Credit Suisse Ag stated it has 17,952 shares or 0% of all its holdings. United Service Automobile Association holds 10,544 shares. Morgan Stanley reported 114,445 shares. Gam Hldgs Ag invested in 14,379 shares or 0.02% of the stock. Toronto Dominion National Bank & Trust invested in 0% or 400 shares. First Manhattan Com accumulated 7,420 shares or 0% of the stock.

Rockshelter Capital Management Llc decreased Linamar Corp. (LIMAF) stake by 25,517 shares to 106,670 valued at $5.83 million in 2018Q1. It also reduced Trinseo Sa (NYSE:TSE) stake by 8,880 shares and now owns 119,134 shares. Berkshire Hathaway Inc. Clas (BRKB) was reduced too.

More notable recent Cara Therapeutics, Inc. (NASDAQ:CARA) news were published by: Nasdaq.com which released: “Cara Therapeutics Announces Dosing of Patients in Phase 2 Trial of Oral KORSUVAâ„¢ (CR845/difelikefalin) for …” on July 11, 2018, also Nasdaq.com with their article: “Is Cara Therapeutics, Inc. a Buy?” published on July 01, 2018, Seekingalpha.com published: “Cara Therapeutics: Worth Keeping An Eye On” on June 28, 2018. More interesting news about Cara Therapeutics, Inc. (NASDAQ:CARA) were released by: Seekingalpha.com and their article: “Cara Therapeutics: Scratching An Itch Left Unscratched” published on June 27, 2018 as well as Nasdaq.com‘s news article titled: “Mid-Afternoon Market Update: US Stocks Turn Negative; Cara Therapeutics Shares Spike Higher” with publication date: June 27, 2018.

Investors sentiment decreased to 0.83 in Q1 2018. Its down 0.10, from 0.93 in 2017Q4. It fall, as 13 investors sold Cara Therapeutics, Inc. shares while 27 reduced holdings. 15 funds opened positions while 18 raised stakes. 15.62 million shares or 1.17% less from 15.80 million shares in 2017Q4 were reported. Morgan Stanley holds 0% or 75,915 shares. Disciplined Growth Incorporated Mn owns 859,565 shares. Ameritas Inv Ptnrs Inc invested in 0% or 2,345 shares. Rho Cap Ptnrs reported 62.3% stake. Td Asset Mngmt Incorporated stated it has 19,200 shares or 0% of all its holdings. Wells Fargo & Communications Mn has 84,697 shares for 0% of their portfolio. Price T Rowe Associate Md has 479,275 shares. Geode Mngmt Limited Liability holds 0% of its portfolio in Cara Therapeutics, Inc. (NASDAQ:CARA) for 229,055 shares. Davenport Limited Liability invested 0% of its portfolio in Cara Therapeutics, Inc. (NASDAQ:CARA). Winslow Evans And Crocker holds 0% or 6,280 shares. Tiverton Asset Mngmt Ltd Liability has 0.01% invested in Cara Therapeutics, Inc. (NASDAQ:CARA) for 14,731 shares. Vantage Invest Ltd Liability Com invested in 0% or 1,350 shares. Stratos Wealth Ltd reported 66 shares stake. Susquehanna Intl Grp Ltd Liability Partnership invested 0% in Cara Therapeutics, Inc. (NASDAQ:CARA). Moreover, Citigroup Inc has 0% invested in Cara Therapeutics, Inc. (NASDAQ:CARA).

Since January 24, 2018, it had 0 buys, and 7 insider sales for $778,740 activity. Menzaghi Frederique Ph.D. had sold 9,000 shares worth $136,710 on Wednesday, May 23. $81,000 worth of stock was sold by CHALMERS DEREK T on Friday, February 16.

Among 5 analysts covering Cara Therapeutics (NASDAQ:CARA), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cara Therapeutics had 9 analyst reports since January 19, 2018 according to SRatingsIntel. The rating was upgraded by Janney Capital to “Buy” on Monday, February 12. The stock of Cara Therapeutics, Inc. (NASDAQ:CARA) has “Buy” rating given on Thursday, March 15 by Canaccord Genuity. The stock of Cara Therapeutics, Inc. (NASDAQ:CARA) has “Buy” rating given on Wednesday, May 23 by H.C. Wainwright. H.C. Wainwright maintained the shares of CARA in report on Monday, March 19 with “Buy” rating. As per Monday, March 12, the company rating was reinitiated by H.C. Wainwright. The company was maintained on Friday, May 11 by H.C. Wainwright. On Thursday, May 24 the stock rating was maintained by Laidlaw with “Buy”. On Friday, June 29 the stock rating was maintained by Canaccord Genuity with “Buy”.

Cara Therapeutics, Inc. (NASDAQ:CARA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.